Walking aid, as its name implies, is a walking aid. Its function is to support weight, maintain standing balance, and assist walking, so as to realize compensation and improve walking ability.
â‘ Provide cushion for rest; â‘¡ Sitting bath board for bathing; â‘¢ Toilet board for auxiliary toilet use; â‘£ Shelves and shopping bags for storing things. Use and carry according to the situation, grasp the measure, and the main purpose is to assist walking.
TRUTECH CO., LTD. is an enterprise specializing in the research, development, production and sales of professional OTC products.The main products include shower chairs, armrests, toilet racks and toilet armrests, bedside armrests, elderly chairs and sofas, crutches and walking aids, knee pads, waist supports and other equipment.
Walker,Hemiplegic Walker Bracke,Health Care Walker,Elderly Walker Medical Treatment TRUTECH CO., LTD. , https://www.trutechealth.com
As an assistive device, walking aids are indispensable in the rehabilitation training process of age, limb disability and limb injury, so how to choose a suitable walking aid is also a learning.
Walking aids are a large category, which can be divided into walking sticks, walking frames and wheelchairs from simple to complex.
What should we pay attention to when using?
1. Adjust the height of the walker according to the user's own conditions. The general principle is correct posture and comfortable use.
2. Necessary inspection shall not be less to ensure safe use.
â‘ Is there any problem with the deployment and storage of the walker; â‘¡ Check whether each part is loose and whether there is burr on the surface of walking aid; â‘¢ Whether the feet or wheels contact the ground smoothly and whether the wheels are flexible; â‘£ The locating pin is not firm, can it be fixed
3. Installation and removal of accessories under specific conditions
Scientists are expected to develop a long-acting, low-toxic HIV drug
Medical Network January 11th, a research report entitled "From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection" published in the international magazine Proceedings of the National Academy of Sciences Researchers from Yale University have successfully tested the effects of a compound on HIV and protecting immune cells, while maintaining a single-week effect on a single dose.
In animal experiments, this compound is expected to be a drug candidate for enhancing current HIV treatments without increasing toxic side effects. This paper is based on previous research by researchers Karen S. Anderson, who used computer- and structure-based design methods to develop a new class of compounds that effectively target proteins that are critical for HIV replication; Researchers have optimized these compounds to enhance their potential, reduce their toxic effects, and improve drug-like properties, with the goal of developing new potential preclinical drug candidates. After joint research, researchers have transplanted humans. This drug candidate was successfully tested in a mouse model of red blood cells and infected with HIV.
In humanized mice, this compound is able to achieve the primary goal of HIV therapy, which inhibits the virus from detecting it in the patient's blood, while also protecting the body's immune cells from viral infections. Compounds can also work in conjunction with currently approved HIV drugs. The researchers found that the protective effect of a single dose of the compound may last for a month, while the compound can be transported with long-acting nanoparticles.
Of course, later researchers need to conduct more in-depth research. They have found that this new compound can effectively improve the current HIV treatment. HIV affects the health of about 37 million people around the world. The combination of HIV drugs in the category, researchers hope that in the future, they can quickly enter human clinical trials, and researchers hope to quickly test their therapeutic potential and the effect of combination therapy on HIV infection.